{"ticker": {"uuid": "fee7d842-2926-49da-b982-b07badc835ff", "symbol": "VRTX", "name": "Vertex Pharmaceuticals Incorporated", "exchange": "VIE", "country": "AT", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Will Pediatric Casgevy Expansion and Canadian ALYFTREK Talks Change Vertex Pharmaceuticals' (VRTX) Narrative?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-18T03:47:09+00:00", "published_display": "18 Jul 2026 03:47", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOSDV4a01ZcnR5VndFbmVYc0t5clpyeTFZRzk1cG5hdDV2VEFyMjJRQkN6cGlKNWEyWjhwb2F5SVhpU2NYMjYxZnFUZGhWSW1JM2JyQ1YwT2dNTmFpVzlaWXlpRDRuQzlqVExlVzZtWC1DSVJXUDhSUFMyaVdVTXRNcy1Kd3QtNHdoNWhobXh5WVNYc3hpWDY4RmZfaTlleURIYUJyVkhfVV9KZ1VJZjFCTmc3YVM?oc=5", "source_name": "Market source", "published_at": "2026-07-16T13:00:03+00:00", "published_display": "16 Jul 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock 6-Day Losing Spree: Stock Falls 10%", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxObTFRckp5QXl4WlhtOGRUZGpfMWZNZjlSdngxOEEtdFA2T3NFSE0zVXE4MWR6dU1PQWlLc3IzQ3JSbFFSWkVRNlpjOG04ay11d1Y0WHo4SUhiQXhoejgwdVR4bWVzNFJ1Z0NOQW9pS1VCTkpaMmMyeWllcUdBMHBRbF9VOEhGZ1FVWVBBMllsT09EVnFGbTZ4ODY4SkUxMkJKYUpNemN6QTN1U1R4a3BlUU40YS1CSTFRS19iTTNxaElVUkhiYkk1S2hzZktiZw?oc=5", "source_name": "Trefis", "published_at": "2026-07-15T14:27:41+00:00", "published_display": "15 Jul 2026 14:27", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock Slides 10% Over 6 Straight Down Days", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPbDVXM0xSMWZVMGozVFQwOE5idmx4Z1ZZckFIQXBKMTZVRDFPei1oTUJOZkJCbjRoZzJGczFfdGFTMzRvR0NSa2R1eXpyX29CR1dZWFc4XzZmYnNGbWhWLWFIVkdEUGgtZUdIaUxmOUl3UlllQnNYcHROUmtPeTZTSjJZcm02V1ZYX0JxZHlOSmhXeEZBYTVnSWhVOUMyUXotQU1kVHBSTndTZElOV0tnNmFFWVY4aFIwbXM5b2pTY3hBOUE?oc=5", "source_name": "Trefis", "published_at": "2026-07-15T13:32:34+00:00", "published_display": "15 Jul 2026 13:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Vertex Pharmaceuticals (VRTX) A Bargain On Its Expanded CASGEVY Approval?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-14T01:02:21+00:00", "published_display": "14 Jul 2026 01:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNOFZFb3RlYmMwclN3cWRoemlYLWo1bnBIOTFSUVdwT3MtczdCR3o0bGVtejd5Q1VHQjJNWjVXWkNlMFZ4OUFXanpucUdCekY2R3dtUzhEOEZlNWVXNjM3U1liQmNUNWFDdFJaVVVqcDROMHJjU29WNXZFZExJR3B0S2ozVXVtX2VmNUk5VkJlMHowYkFQWTIzekNReUpVVVE1ZGdSWEVNZVJ2Zw?oc=5", "source_name": "Market source", "published_at": "2026-07-13T22:00:06+00:00", "published_display": "13 Jul 2026 22:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What to Expect From Vertex Pharmaceuticals' Next Quarterly Earnings Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxONUQ2VlFPbVlkZUpuOXlEZ1pTOWdFOV91bWlXWm5ZTGVQTzlzbDlMT3ZfcHVZemdzZ1hQaUhxSkZPLXM5a2pOZ0tzem9MSUkyZ1d3MEZYcFo4NzJka0RHbUFnZU11ZnpmMWczY3NYUzd2ZzlQNEVsczVWbmtQaVJsckJDV1lzZUpvYm9NY0dfbUgya2NLYkJCNFdrQzJ0ZWdqOU0xanVwR2o?oc=5", "source_name": "Market source", "published_at": "2026-07-13T13:57:25+00:00", "published_display": "13 Jul 2026 13:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals shares drop over 4% after Crinetics Pharmaceuticals $10B all-cash acquisition news", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOdEZCb1luS1BvNEI3OUsxWmZuWURFYldwb29XanZjeG1rVUxYSXdqcEFlcVJpNVNLQmZWSE0xX0FlTEpsQ2NJWHZXSUxzSHFlNDMwUnYteVJ6NzRvUU5RbzJETkJ4U29DaGphbUlzbFdvbXMySzlQRnBLYWNzUkhHdkRzZmJwTlVzcW45Vi1ybk1HUVpFU1NGMmZMdDhGcUN6?oc=5", "source_name": "Traders Union", "published_at": "2026-07-08T19:25:29+00:00", "published_display": "08 Jul 2026 19:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (VRTX) Stock May Be 36% Undervalued Following Its $10b Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNTk9HVDlSOUNLT1UtdHJneGNsa0JNaURYMFBZSDFTMGJlV19vb2NlUzcwTzFUbHIxMWhhdUhqSUs0b2prdUdTUTdGZ3hUQkt4Y09hMC1DMHVGMENIX1E4MVFMUjVSUllMOVJQRUtQdTM1ejZJNldGVkhaRjRsQVR4dWRodGJkM09xNzk2WmVrZ3h3ZXc?oc=5", "source_name": "Market source", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals stock trades up to $529.75 as VertexPharma announces Crinetics acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNVDdUUEk3amdBNFo4YjhGcTRwZVowVUI1Uy1pU0w1cG9SMkI1Qk85cWpYYV9TaEFRWkVGOEI2U25YMnhpRzVfQWRpVHJyWE9Jbl9teTNqald3cUxfbndZZ2ExQ0lKOHRBMFgtTmJpa2JvMFF6a1d3ZnBkMFNLVHVicTZKckFMLVJ3eEg5NEdaWjM0Umg1YmJ6V09iQXhpQQ?oc=5", "source_name": "Traders Union", "published_at": "2026-07-07T00:05:16+00:00", "published_display": "07 Jul 2026 00:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPYlVZTzFkVUEzUW15a3hzT0F5ek8wbkZTMzB0U0FWakxPWlptZkNDN3AwLXNWdWxEa0FBOFBHTDFNZWNZeTluaUhBelc5MXotU19xeEhRMnVzYkw5RzFLc2xGZlYza2pxdEh2WTlkZF8tRDY3blBzb1NKZVQ0TU50ZTFSRkRYX25FSm9JWjEtdGtXN1NhVlFuREtibXZWZ0IxcEU2LXlBMnB2a2hWNWZiV3VR?oc=5", "source_name": "Market source", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Therapeutics Stocks Q1 Recap: Benchmarking Vertex Pharmaceuticals (NASDAQ:VRTX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxON3BqVTItcnd6N240MndjX0c3ekdidmlJTDZMRU1pMVlVMUpDWU94cDdEcUZLdkNJUF9Fd1JCd19PUXVUUC16cDFwdUpwX0U0NEtBamJueHh1eUo0WWVMdkZPMmtEQy03dzY3S3Zld056eVUwQ1dyaW1oTkpJQl93OU1YRlV2ZDhGay0tajBqYi1idTVLMHd6LVR2SG93MmFpZTN4WQ?oc=5", "source_name": "Market source", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOYUJCRHpLdzhuNmcxVnZLVUVLSWc3U0JqNVpuOHNLbmMwZmE4NG1Yb2M3Xy1CMUk0T1hjM3VmeEpTV2xJMmVTX1BiMk5VOG93WS1TeG1fQ2NlYk44cHBfQzFTZ2U1UERQSHlYU2lDeG1SQzNMOVJyazRvSDdVZ0JuMUtMbGdSU2xVXzBuRjdDN2dwaUd5Y1pXdVQwZ3h2alFHb0k3ZE9CVUM?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Positive Pediatric CASGEVY Data Might Change The Case For Investing In Vertex Pharmaceuticals (VRTX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPNzJydi1RUXhvaVExQVVJWnhpYjEyb3NOVHJheExOYmsyLU5famxjRnRWdS1TSDJLWjZNUmtEa3RLNkZxaGVtYWNPSmFLSFJnNktJWDVHSk9DVFlmVVdLLWRmWHdiR19LZXpWZm9MWlU4VkVOOGp0QktVX3ZmdWtiZ25BSS05SzVqaEtacm9fSGI4bzcyMVN0RTNIWWFCaTA?oc=5", "source_name": "Market source", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock After Strong Multi\u2011Year Run Is The Price Still Reasonable", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNVW9halB2RDE0V056SmV5NEd0Wl95ekI0eWM3QzVsckpLQ2RMWkF3SWRMSUFmMlViUHBObGVobXhwYW5CWU42WG5NUG45WHhDNGEzcHlheG1hM1lZWkpTOUs3UFFmUHdDOUw2V2tEV0N4YnlMY0d0cmswalo4WnZzTWlVZGd6ZmdyeW5WSXZJRFplSFkyRnREQnlJaVN4MFA3WS1uWU55blg?oc=5", "source_name": "Market source", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rockefeller Capital stake increase propels Vertex Pharmaceuticals stock higher by 3.42%", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPeU1nRXRmYzRLWkg1NnQ0dXhoZkFnV1doc3NFNVdqQXVuNWZUTFJPLWE1VGZNZUpENW9MbjhhcW9Rc2ptb1hseDhrWkhFZzJESEY3QTFnc0Z4VkxQNzA4LU5HYjBFVjEzR0xtRGhKYjJxNHhJNGFiVXFDVi1xME9RNVllRGx0TjZuNWw0OXBHNFhEQXpHaWlkUDgtNHNtOUdqcjFXVi1QV3I?oc=5", "source_name": "Traders Union", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Vertex Pharmaceuticals stock up today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPZXg1ZGpldGE0d2E5ZXBJWVE1U0JiWHpfOFlMQVdOY1ctZ3cycW1yVjlFRGg1LVVJZDlrSFZjVDBSUmpJa3l6Q2t0eFVyc09jcG84a0JEamtURWFsa1A5d2VmalE0TmYtYkZlV2tHYjUyT19LNzVHd1ZoVE5PMEtEWlZIaVNyNUdHdFR5ZjZkdExGM2FRMVpEVDhDNjVSNGE2NVJBcFphamM?oc=5", "source_name": "Traders Union", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sustained momentum drives Vertex Pharmaceuticals stock higher despite signs of overbought conditions", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQQy0xWnN2aUptYjhfUXFfSWxwZTVhU1M4TFN5OURISmtaT1BRTWx6MS1aZ3AtNkN2eVdIY2JLTGRrNnFMcHJITFBubnNzNjdOcFFHVXBWV1lCM1JPYTJEbkU1UW43MDVTT0c5T0F3QU5hQ2tjY0pIRlNnNWtpNjZWSk1ZU2l1ellrcUtnbFh2bHhoY3VkY3BRcGdFNHNPVWw3dzREcg?oc=5", "source_name": "Traders Union", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Vertex Pharmaceuticals stock down today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPZGoyQ2xuV3pvNVU3UlBraG94QzVhbmZuaG81by1SbHlTY19BSXJkeGVUZDU4WnlTUkwyd2U0QTkwWWpTdFJBTlBZblhGY25HQm5hYzBTWTE3RHZrNVlnRWptcTRnMTg5b3hvOXpia2FLbmNqMXZWWFI1ZHhXVW9mN2h0U1JWbGtIVUVvWUVvaGtTaTVpWFZoYkp2emI5elpMUGpvRkpBRGtLQQ?oc=5", "source_name": "Traders Union", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Vertex Pharmaceuticals (VRTX) Offering An Opportunity After Recent Share Price Consolidation?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPcWMwYWZZaUg0UXcyV2UzR2RLeWJQYVZLWmJBakdUSDJQWWh3aUZaR3BpbVAzR1c2eDRmSzBoR0FJQjlfNVhYZjdmMTNxUm81OXJwaGhza1lYRm1OVXZHMDd1LUUwSDBzNzQzREwyWDAtenRZQVRBR1ZsT1FXbXhxWmxXWHU5SDZ1SlNTdFpBUXJNclVGSXBRMUpJc0lvRFNNemw2TnJ1aVlUYk01VHhFVThEaw?oc=5", "source_name": "Market source", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals shares dip amid rising selling pressure", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNR1dURXFXLXJaM3BFUzJhSjluTzNodDdFbkRTRklNOW9CelYyRGhZSW1BSG9Rd1VDWFhaWF9CTnRvQ0RHcjVxU1plSDNDbTJvTS04ZVhHYmhuZXIyY1QxRVN2Ti1KUWotWUcxWllsRmhNWU50TXBYbzd0aDl6ZkpHYVFGcE9HY3pxODZpVlB6ZnIzTEJkdklBOQ?oc=5", "source_name": "Traders Union", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Buying pressure lifts Vertex Pharmaceuticals stock higher in today's trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNUERGMV9rdmJWVm1hc00tMVZZMmJpR2tieTZjQ29UQ0F3bUpNdzRtNHJ6TEY4NDBhNEY1X3R3T2hVU3Atd0d3VmVhWndEa2pZUnR2WXNjcnBoSTUxQ3RiN2lvRHJPY1MzQkRBWHB4aEFpMlprY2N1dzFSZDIyYmpHSy1ldWRZaEV4OUg3VVpTTUNkbmZhS213?oc=5", "source_name": "Traders Union", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock Analysis: 1991 IPO Growth and 2026 Outlook - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPWDdRcmJnTUNiVGhhT0JTbEFuUzBQMm1JMmdoeFMxdld2TzM2LU8zZ2U4TWY5R0NRV2ZhX3dOT0pOS1JxekZwSERNZ1B2cDNkSFBNQUtBVVdhZVd0VHkxa1dpQlo0WTVNbXh5VXBWal9jOUdjZDVOQXg1N1UwdGN5LW14Q2YxLTZxR2xlVFA2SGpvOHRVWjlpNm5VTEZHZw?oc=5", "source_name": "IndexBox", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Germany backs access to Vertex's one-time gene therapy for blood disorders", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxORXRLc2s1bno2ZkhZVFBiaDVXQ3dSSEZJU19xQkw5RGVMRUtGMXp1R2RFMkV0MlRsWHppNkwtQ1lTOFNndnJjYzEzVmhlSDMySHdSY0QzUmo2WWp2elBKVmVJT2p6dlBOT2ltTU5aMWNfYXRGcVJwREY3XzIwbjlSd1VwQnlpOUpKQUdTS3RQYzV3QjRFLXZ3NFhQVXhhNjY1cjlvUWF6R1dqeS1HYzgzenBxV292clhnQTBCelBB?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-06T11:04:39+00:00", "published_display": "06 May 2026 11:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Q1 2026 Earnings Preview: Revenue Growth of 6.5% Expected", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNcHN0bzFPR2JFYWl4dnhFTDRTczh1LTZ4VnVZMnVvcFlyRHUydUxGSW8zUUl4RHB3dTlBd2dkLTlFS2pxOTBSTzhHd3dJdmM4T0prWXBXZXZTVzZldnM1Z3NwdFNObldvSmhtOGlFOXRDeF9RVzRfakdIOGJuc3VmNVZJeGJJemNXLVRBXzdxNlNjTGtZUFlDZVlpejRSanhYWTkza0lycjJxd1E?oc=5", "source_name": "IndexBox", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(VRTX) Vertex Pharmaceuticals Expects 2026 Revenue Range $12.95B-$13.1B, vs. FactSet Est of $13.05B", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOR2tCT09Sc0RWSllSMjdyWGZlc2V2RWRIbDZnMjNYWUJkb29taEpRakY0R2RQUUh1TW9sYnVsWWJuWkRhaDk3dUJlSlBqZFA0VXNETUZrUzRsUHJHakRMU2tPa3RlM3B0ZE5nUDBpbjB5d1V4ai1UaHJ4OUFjRUVTbUVwUXFZVEhWZDA5WUJNVkVLZ2o5UDZyTzBrZ3luQ0VZTFhFeHlCT3FxVHA0SFY1Vm5IeUEwS0lDREVMYjl1djRCM3FsdENzOU94dHMzM0MyYnFYeDJ5Q0M4ek95Y0E?oc=5", "source_name": "marketscreener.com", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPNWgxZmFPcUY5cHVqUjNNZ2pHVDE5Y0FJdnZBYmxLQlBKZnlGMC10UExaNUdzc0U1cWQxbmVKa1gzekFIazRWN3RsTTFKTGU0bURmV0dSbFVvVllDQS1mNnprR3lGQUxEQnNLR1FPWWhVdDZOVE9fRWZ4THNNQzdoUnk3ajg4amROUE9oUXBzWDFRUjg5N3c5ZzZ4S1NoeEkyNFY1OWVkQQ?oc=5", "source_name": "Market source", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock Slides as Market Rises: Facts to Know Before You Trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQR3pDcWtZWjd1c1dwOTlpY0cwZUJkYWJCLVBlS0o0Y0ctOE5ENUh5b2dicHhSdGxmR19XblF0UzgtQkVaOTM1ZnFGcl85bS1DMGYtRzI5bTZwMVByeWs5YmVYcVR5elM4cjVHVmQ3aHpHWlRScUFKRWxtUVl3c3lhcFpndWt5MlVJY0xpdUpiRkNsUk84U3kyVHZLT2tPT3F5am40bE9YWFA?oc=5", "source_name": "Market source", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPdXIxTVd1ZHVTWmF3Tk55OHVsWW1aa204VXlzNkZuQWpfaGJkRjhlRncxRkZUb2ctYlJLV1hiY0QxYlFzMW9OS1A1WjlzaDhrclNGZUtXZ1gyRVNaTDRkUi1PcjBnVTBiVnpFaGdQWVBDRjh6b2FNZVNHcndESkNydFByQWVVTE9yU2RoUnZMSTFVdGdNakt0TlpoNXg5SnRDaWZSMUprbw?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock Rises 5% on Kidney Drug Trial Win", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPVkRkVnoyMmMwajlJXzFjR1FyTU5ncWNSTk1IakJDLUNDY0VFWEVvYkUtajQ2MG5DWEdwOHM3WkYtWnNlVDlvc2VPMFFDejRoSnJrTlRZZ0FhRDVCUElaUThSUU1ReEZoTjVfUG00Yk9wRGkxVWc2SWIyQ1MtZmltQTd3aUV2dkVpNnZlaEt5SEFlTzlUbkE?oc=5", "source_name": "CoinCentral", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Non-opioid pain pill and gene therapy help fuel Vertex\u2019s $12B year", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPLUtTNTNqRlNnTENfQkx1ZTU4WDBpbC1Da1llaERQSTZES0g3c1c3U2VDNnBvNHZURWg5ZUJnX2F4TWxXSDNFMWpCOVBRODZjUDZadFlmTDVRdElTQmdTazFaWUVwLXVtYlJ5Y0xBc2oxeXFDUExLOVNqT3JXY2QwMzRJRngwNTh6YzA3dGI2ZnBzSGFZb05vZ3NhQlQ1eE9velBabF80ZHVfOEJMa1FCTUpyMA?oc=5", "source_name": "Stock Titan", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "VERTEX PHARMACEUTICALS INCORPORATED", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxOcDhWd2t3ZVp5OW0wRWVWSVA2M2QxRmpNRFkwVGFTejJ4Q19ycmJPTTNXZWpuWUtmWTdyLUNaT3dlUmEtYkw5SDJVZElzRHRDeU1ual9ndm1sZ3p5UUI1MnpEOGhMSXlYdkxrU195cmxzTXo4cnVDQlk5anowVXd2cnROa1VEMjRlZE1KamZn?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-26T17:52:16+00:00", "published_display": "26 Aug 2020 17:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Will Pediatric Casgevy Expansion and Canadian ALYFTREK Talks Change Vertex Pharmaceuticals' (VRTX) Narrative?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-18T03:47:09+00:00", "published_display": "18 Jul 2026 03:47", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOSDV4a01ZcnR5VndFbmVYc0t5clpyeTFZRzk1cG5hdDV2VEFyMjJRQkN6cGlKNWEyWjhwb2F5SVhpU2NYMjYxZnFUZGhWSW1JM2JyQ1YwT2dNTmFpVzlaWXlpRDRuQzlqVExlVzZtWC1DSVJXUDhSUFMyaVdVTXRNcy1Kd3QtNHdoNWhobXh5WVNYc3hpWDY4RmZfaTlleURIYUJyVkhfVV9KZ1VJZjFCTmc3YVM?oc=5", "source_name": "Market source", "published_at": "2026-07-16T13:00:03+00:00", "published_display": "16 Jul 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock 6-Day Losing Spree: Stock Falls 10%", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxObTFRckp5QXl4WlhtOGRUZGpfMWZNZjlSdngxOEEtdFA2T3NFSE0zVXE4MWR6dU1PQWlLc3IzQ3JSbFFSWkVRNlpjOG04ay11d1Y0WHo4SUhiQXhoejgwdVR4bWVzNFJ1Z0NOQW9pS1VCTkpaMmMyeWllcUdBMHBRbF9VOEhGZ1FVWVBBMllsT09EVnFGbTZ4ODY4SkUxMkJKYUpNemN6QTN1U1R4a3BlUU40YS1CSTFRS19iTTNxaElVUkhiYkk1S2hzZktiZw?oc=5", "source_name": "Trefis", "published_at": "2026-07-15T14:27:41+00:00", "published_display": "15 Jul 2026 14:27", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock Slides 10% Over 6 Straight Down Days", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPbDVXM0xSMWZVMGozVFQwOE5idmx4Z1ZZckFIQXBKMTZVRDFPei1oTUJOZkJCbjRoZzJGczFfdGFTMzRvR0NSa2R1eXpyX29CR1dZWFc4XzZmYnNGbWhWLWFIVkdEUGgtZUdIaUxmOUl3UlllQnNYcHROUmtPeTZTSjJZcm02V1ZYX0JxZHlOSmhXeEZBYTVnSWhVOUMyUXotQU1kVHBSTndTZElOV0tnNmFFWVY4aFIwbXM5b2pTY3hBOUE?oc=5", "source_name": "Trefis", "published_at": "2026-07-15T13:32:34+00:00", "published_display": "15 Jul 2026 13:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Vertex Pharmaceuticals (VRTX) A Bargain On Its Expanded CASGEVY Approval?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-14T01:02:21+00:00", "published_display": "14 Jul 2026 01:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNOFZFb3RlYmMwclN3cWRoemlYLWo1bnBIOTFSUVdwT3MtczdCR3o0bGVtejd5Q1VHQjJNWjVXWkNlMFZ4OUFXanpucUdCekY2R3dtUzhEOEZlNWVXNjM3U1liQmNUNWFDdFJaVVVqcDROMHJjU29WNXZFZExJR3B0S2ozVXVtX2VmNUk5VkJlMHowYkFQWTIzekNReUpVVVE1ZGdSWEVNZVJ2Zw?oc=5", "source_name": "Market source", "published_at": "2026-07-13T22:00:06+00:00", "published_display": "13 Jul 2026 22:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What to Expect From Vertex Pharmaceuticals' Next Quarterly Earnings Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxONUQ2VlFPbVlkZUpuOXlEZ1pTOWdFOV91bWlXWm5ZTGVQTzlzbDlMT3ZfcHVZemdzZ1hQaUhxSkZPLXM5a2pOZ0tzem9MSUkyZ1d3MEZYcFo4NzJka0RHbUFnZU11ZnpmMWczY3NYUzd2ZzlQNEVsczVWbmtQaVJsckJDV1lzZUpvYm9NY0dfbUgya2NLYkJCNFdrQzJ0ZWdqOU0xanVwR2o?oc=5", "source_name": "Market source", "published_at": "2026-07-13T13:57:25+00:00", "published_display": "13 Jul 2026 13:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals shares drop over 4% after Crinetics Pharmaceuticals $10B all-cash acquisition news", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOdEZCb1luS1BvNEI3OUsxWmZuWURFYldwb29XanZjeG1rVUxYSXdqcEFlcVJpNVNLQmZWSE0xX0FlTEpsQ2NJWHZXSUxzSHFlNDMwUnYteVJ6NzRvUU5RbzJETkJ4U29DaGphbUlzbFdvbXMySzlQRnBLYWNzUkhHdkRzZmJwTlVzcW45Vi1ybk1HUVpFU1NGMmZMdDhGcUN6?oc=5", "source_name": "Traders Union", "published_at": "2026-07-08T19:25:29+00:00", "published_display": "08 Jul 2026 19:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex (VRTX) Stock May Be 36% Undervalued Following Its $10b Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNTk9HVDlSOUNLT1UtdHJneGNsa0JNaURYMFBZSDFTMGJlV19vb2NlUzcwTzFUbHIxMWhhdUhqSUs0b2prdUdTUTdGZ3hUQkt4Y09hMC1DMHVGMENIX1E4MVFMUjVSUllMOVJQRUtQdTM1ejZJNldGVkhaRjRsQVR4dWRodGJkM09xNzk2WmVrZ3h3ZXc?oc=5", "source_name": "Market source", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals stock trades up to $529.75 as VertexPharma announces Crinetics acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNVDdUUEk3amdBNFo4YjhGcTRwZVowVUI1Uy1pU0w1cG9SMkI1Qk85cWpYYV9TaEFRWkVGOEI2U25YMnhpRzVfQWRpVHJyWE9Jbl9teTNqald3cUxfbndZZ2ExQ0lKOHRBMFgtTmJpa2JvMFF6a1d3ZnBkMFNLVHVicTZKckFMLVJ3eEg5NEdaWjM0Umg1YmJ6V09iQXhpQQ?oc=5", "source_name": "Traders Union", "published_at": "2026-07-07T00:05:16+00:00", "published_display": "07 Jul 2026 00:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPYlVZTzFkVUEzUW15a3hzT0F5ek8wbkZTMzB0U0FWakxPWlptZkNDN3AwLXNWdWxEa0FBOFBHTDFNZWNZeTluaUhBelc5MXotU19xeEhRMnVzYkw5RzFLc2xGZlYza2pxdEh2WTlkZF8tRDY3blBzb1NKZVQ0TU50ZTFSRkRYX25FSm9JWjEtdGtXN1NhVlFuREtibXZWZ0IxcEU2LXlBMnB2a2hWNWZiV3VR?oc=5", "source_name": "Market source", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Therapeutics Stocks Q1 Recap: Benchmarking Vertex Pharmaceuticals (NASDAQ:VRTX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxON3BqVTItcnd6N240MndjX0c3ekdidmlJTDZMRU1pMVlVMUpDWU94cDdEcUZLdkNJUF9Fd1JCd19PUXVUUC16cDFwdUpwX0U0NEtBamJueHh1eUo0WWVMdkZPMmtEQy03dzY3S3Zld056eVUwQ1dyaW1oTkpJQl93OU1YRlV2ZDhGay0tajBqYi1idTVLMHd6LVR2SG93MmFpZTN4WQ?oc=5", "source_name": "Market source", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOYUJCRHpLdzhuNmcxVnZLVUVLSWc3U0JqNVpuOHNLbmMwZmE4NG1Yb2M3Xy1CMUk0T1hjM3VmeEpTV2xJMmVTX1BiMk5VOG93WS1TeG1fQ2NlYk44cHBfQzFTZ2U1UERQSHlYU2lDeG1SQzNMOVJyazRvSDdVZ0JuMUtMbGdSU2xVXzBuRjdDN2dwaUd5Y1pXdVQwZ3h2alFHb0k3ZE9CVUM?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Positive Pediatric CASGEVY Data Might Change The Case For Investing In Vertex Pharmaceuticals (VRTX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPNzJydi1RUXhvaVExQVVJWnhpYjEyb3NOVHJheExOYmsyLU5famxjRnRWdS1TSDJLWjZNUmtEa3RLNkZxaGVtYWNPSmFLSFJnNktJWDVHSk9DVFlmVVdLLWRmWHdiR19LZXpWZm9MWlU4VkVOOGp0QktVX3ZmdWtiZ25BSS05SzVqaEtacm9fSGI4bzcyMVN0RTNIWWFCaTA?oc=5", "source_name": "Market source", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock After Strong Multi\u2011Year Run Is The Price Still Reasonable", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNVW9halB2RDE0V056SmV5NEd0Wl95ekI0eWM3QzVsckpLQ2RMWkF3SWRMSUFmMlViUHBObGVobXhwYW5CWU42WG5NUG45WHhDNGEzcHlheG1hM1lZWkpTOUs3UFFmUHdDOUw2V2tEV0N4YnlMY0d0cmswalo4WnZzTWlVZGd6ZmdyeW5WSXZJRFplSFkyRnREQnlJaVN4MFA3WS1uWU55blg?oc=5", "source_name": "Market source", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rockefeller Capital stake increase propels Vertex Pharmaceuticals stock higher by 3.42%", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPeU1nRXRmYzRLWkg1NnQ0dXhoZkFnV1doc3NFNVdqQXVuNWZUTFJPLWE1VGZNZUpENW9MbjhhcW9Rc2ptb1hseDhrWkhFZzJESEY3QTFnc0Z4VkxQNzA4LU5HYjBFVjEzR0xtRGhKYjJxNHhJNGFiVXFDVi1xME9RNVllRGx0TjZuNWw0OXBHNFhEQXpHaWlkUDgtNHNtOUdqcjFXVi1QV3I?oc=5", "source_name": "Traders Union", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Vertex Pharmaceuticals stock up today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPZXg1ZGpldGE0d2E5ZXBJWVE1U0JiWHpfOFlMQVdOY1ctZ3cycW1yVjlFRGg1LVVJZDlrSFZjVDBSUmpJa3l6Q2t0eFVyc09jcG84a0JEamtURWFsa1A5d2VmalE0TmYtYkZlV2tHYjUyT19LNzVHd1ZoVE5PMEtEWlZIaVNyNUdHdFR5ZjZkdExGM2FRMVpEVDhDNjVSNGE2NVJBcFphamM?oc=5", "source_name": "Traders Union", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sustained momentum drives Vertex Pharmaceuticals stock higher despite signs of overbought conditions", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQQy0xWnN2aUptYjhfUXFfSWxwZTVhU1M4TFN5OURISmtaT1BRTWx6MS1aZ3AtNkN2eVdIY2JLTGRrNnFMcHJITFBubnNzNjdOcFFHVXBWV1lCM1JPYTJEbkU1UW43MDVTT0c5T0F3QU5hQ2tjY0pIRlNnNWtpNjZWSk1ZU2l1ellrcUtnbFh2bHhoY3VkY3BRcGdFNHNPVWw3dzREcg?oc=5", "source_name": "Traders Union", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Vertex Pharmaceuticals stock down today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPZGoyQ2xuV3pvNVU3UlBraG94QzVhbmZuaG81by1SbHlTY19BSXJkeGVUZDU4WnlTUkwyd2U0QTkwWWpTdFJBTlBZblhGY25HQm5hYzBTWTE3RHZrNVlnRWptcTRnMTg5b3hvOXpia2FLbmNqMXZWWFI1ZHhXVW9mN2h0U1JWbGtIVUVvWUVvaGtTaTVpWFZoYkp2emI5elpMUGpvRkpBRGtLQQ?oc=5", "source_name": "Traders Union", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Vertex Pharmaceuticals (VRTX) Offering An Opportunity After Recent Share Price Consolidation?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPcWMwYWZZaUg0UXcyV2UzR2RLeWJQYVZLWmJBakdUSDJQWWh3aUZaR3BpbVAzR1c2eDRmSzBoR0FJQjlfNVhYZjdmMTNxUm81OXJwaGhza1lYRm1OVXZHMDd1LUUwSDBzNzQzREwyWDAtenRZQVRBR1ZsT1FXbXhxWmxXWHU5SDZ1SlNTdFpBUXJNclVGSXBRMUpJc0lvRFNNemw2TnJ1aVlUYk01VHhFVThEaw?oc=5", "source_name": "Market source", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals shares dip amid rising selling pressure", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNR1dURXFXLXJaM3BFUzJhSjluTzNodDdFbkRTRklNOW9CelYyRGhZSW1BSG9Rd1VDWFhaWF9CTnRvQ0RHcjVxU1plSDNDbTJvTS04ZVhHYmhuZXIyY1QxRVN2Ti1KUWotWUcxWllsRmhNWU50TXBYbzd0aDl6ZkpHYVFGcE9HY3pxODZpVlB6ZnIzTEJkdklBOQ?oc=5", "source_name": "Traders Union", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Buying pressure lifts Vertex Pharmaceuticals stock higher in today's trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNUERGMV9rdmJWVm1hc00tMVZZMmJpR2tieTZjQ29UQ0F3bUpNdzRtNHJ6TEY4NDBhNEY1X3R3T2hVU3Atd0d3VmVhWndEa2pZUnR2WXNjcnBoSTUxQ3RiN2lvRHJPY1MzQkRBWHB4aEFpMlprY2N1dzFSZDIyYmpHSy1ldWRZaEV4OUg3VVpTTUNkbmZhS213?oc=5", "source_name": "Traders Union", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock Analysis: 1991 IPO Growth and 2026 Outlook - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPWDdRcmJnTUNiVGhhT0JTbEFuUzBQMm1JMmdoeFMxdld2TzM2LU8zZ2U4TWY5R0NRV2ZhX3dOT0pOS1JxekZwSERNZ1B2cDNkSFBNQUtBVVdhZVd0VHkxa1dpQlo0WTVNbXh5VXBWal9jOUdjZDVOQXg1N1UwdGN5LW14Q2YxLTZxR2xlVFA2SGpvOHRVWjlpNm5VTEZHZw?oc=5", "source_name": "IndexBox", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Germany backs access to Vertex's one-time gene therapy for blood disorders", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxORXRLc2s1bno2ZkhZVFBiaDVXQ3dSSEZJU19xQkw5RGVMRUtGMXp1R2RFMkV0MlRsWHppNkwtQ1lTOFNndnJjYzEzVmhlSDMySHdSY0QzUmo2WWp2elBKVmVJT2p6dlBOT2ltTU5aMWNfYXRGcVJwREY3XzIwbjlSd1VwQnlpOUpKQUdTS3RQYzV3QjRFLXZ3NFhQVXhhNjY1cjlvUWF6R1dqeS1HYzgzenBxV292clhnQTBCelBB?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-06T11:04:39+00:00", "published_display": "06 May 2026 11:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Q1 2026 Earnings Preview: Revenue Growth of 6.5% Expected", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNcHN0bzFPR2JFYWl4dnhFTDRTczh1LTZ4VnVZMnVvcFlyRHUydUxGSW8zUUl4RHB3dTlBd2dkLTlFS2pxOTBSTzhHd3dJdmM4T0prWXBXZXZTVzZldnM1Z3NwdFNObldvSmhtOGlFOXRDeF9RVzRfakdIOGJuc3VmNVZJeGJJemNXLVRBXzdxNlNjTGtZUFlDZVlpejRSanhYWTkza0lycjJxd1E?oc=5", "source_name": "IndexBox", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(VRTX) Vertex Pharmaceuticals Expects 2026 Revenue Range $12.95B-$13.1B, vs. FactSet Est of $13.05B", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOR2tCT09Sc0RWSllSMjdyWGZlc2V2RWRIbDZnMjNYWUJkb29taEpRakY0R2RQUUh1TW9sYnVsWWJuWkRhaDk3dUJlSlBqZFA0VXNETUZrUzRsUHJHakRMU2tPa3RlM3B0ZE5nUDBpbjB5d1V4ai1UaHJ4OUFjRUVTbUVwUXFZVEhWZDA5WUJNVkVLZ2o5UDZyTzBrZ3luQ0VZTFhFeHlCT3FxVHA0SFY1Vm5IeUEwS0lDREVMYjl1djRCM3FsdENzOU94dHMzM0MyYnFYeDJ5Q0M4ek95Y0E?oc=5", "source_name": "marketscreener.com", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPNWgxZmFPcUY5cHVqUjNNZ2pHVDE5Y0FJdnZBYmxLQlBKZnlGMC10UExaNUdzc0U1cWQxbmVKa1gzekFIazRWN3RsTTFKTGU0bURmV0dSbFVvVllDQS1mNnprR3lGQUxEQnNLR1FPWWhVdDZOVE9fRWZ4THNNQzdoUnk3ajg4amROUE9oUXBzWDFRUjg5N3c5ZzZ4S1NoeEkyNFY1OWVkQQ?oc=5", "source_name": "Market source", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock Slides as Market Rises: Facts to Know Before You Trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQR3pDcWtZWjd1c1dwOTlpY0cwZUJkYWJCLVBlS0o0Y0ctOE5ENUh5b2dicHhSdGxmR19XblF0UzgtQkVaOTM1ZnFGcl85bS1DMGYtRzI5bTZwMVByeWs5YmVYcVR5elM4cjVHVmQ3aHpHWlRScUFKRWxtUVl3c3lhcFpndWt5MlVJY0xpdUpiRkNsUk84U3kyVHZLT2tPT3F5am40bE9YWFA?oc=5", "source_name": "Market source", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPdXIxTVd1ZHVTWmF3Tk55OHVsWW1aa204VXlzNkZuQWpfaGJkRjhlRncxRkZUb2ctYlJLV1hiY0QxYlFzMW9OS1A1WjlzaDhrclNGZUtXZ1gyRVNaTDRkUi1PcjBnVTBiVnpFaGdQWVBDRjh6b2FNZVNHcndESkNydFByQWVVTE9yU2RoUnZMSTFVdGdNakt0TlpoNXg5SnRDaWZSMUprbw?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock Rises 5% on Kidney Drug Trial Win", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPVkRkVnoyMmMwajlJXzFjR1FyTU5ncWNSTk1IakJDLUNDY0VFWEVvYkUtajQ2MG5DWEdwOHM3WkYtWnNlVDlvc2VPMFFDejRoSnJrTlRZZ0FhRDVCUElaUThSUU1ReEZoTjVfUG00Yk9wRGkxVWc2SWIyQ1MtZmltQTd3aUV2dkVpNnZlaEt5SEFlTzlUbkE?oc=5", "source_name": "CoinCentral", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Non-opioid pain pill and gene therapy help fuel Vertex\u2019s $12B year", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPLUtTNTNqRlNnTENfQkx1ZTU4WDBpbC1Da1llaERQSTZES0g3c1c3U2VDNnBvNHZURWg5ZUJnX2F4TWxXSDNFMWpCOVBRODZjUDZadFlmTDVRdElTQmdTazFaWUVwLXVtYlJ5Y0xBc2oxeXFDUExLOVNqT3JXY2QwMzRJRngwNTh6YzA3dGI2ZnBzSGFZb05vZ3NhQlQ1eE9velBabF80ZHVfOEJMa1FCTUpyMA?oc=5", "source_name": "Stock Titan", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "VERTEX PHARMACEUTICALS INCORPORATED", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxOcDhWd2t3ZVp5OW0wRWVWSVA2M2QxRmpNRFkwVGFTejJ4Q19ycmJPTTNXZWpuWUtmWTdyLUNaT3dlUmEtYkw5SDJVZElzRHRDeU1ual9ndm1sZ3p5UUI1MnpEOGhMSXlYdkxrU195cmxzTXo4cnVDQlk5anowVXd2cnROa1VEMjRlZE1KamZn?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-26T17:52:16+00:00", "published_display": "26 Aug 2020 17:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 86, "total_relevant": 32, "sentiment_summary": {"positive": 10, "negative": 2, "neutral": 20, "score": 52, "total": 32, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 12.65, "count": 23}, {"event": "deals", "label": "Deals and strategy", "weight": 2.2, "count": 4}, {"event": "earnings", "label": "Earnings", "weight": 1.65, "count": 3}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 10, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 424.75, "latest_week": "2026-07-10", "one_week_move": -7.8, "four_week_move": 11.1, "twelve_week_move": 14.5, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.201372, "market_dynamics_buy_signal": false, "relative_strength": -8.708478, "fair_value_gap": 8.3, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 53.8372, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-7.8% over one week, +11.1% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 13}, {"label": "Traders Union", "count": 8}, {"label": "simplywall.st", "count": 2}, {"label": "Trefis", "count": 2}, {"label": "IndexBox", "count": 2}, {"label": "Stock Titan", "count": 2}, {"label": "marketscreener.com", "count": 2}, {"label": "CoinCentral", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 32}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 23}, {"label": "Deals and strategy", "count": 4}, {"label": "Earnings", "count": 3}, {"label": "Regulatory and legal", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 classification confidence."}, {"label": "Company focus", "value": "32", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-7.8% over one week, +11.1% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Will Pediatric Casgevy Expansion and Canadian ALYFTREK Talks Change Vertex Pharmaceuticals' (VRTX) Narrative?"}], "updated_at": "2026-07-18T05:27:03.477852+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}